DIA 2013 49th Annual Meeting
Click here to go to the previous page
Evaluating Sites for Optimum Site Selection and Performance
Track : Track 01: Clinical Operations
Program Code: 266
Date: Tuesday, June 25, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 205C
CHAIR :
 Scott R Martin, JD,MA (SCHNON), Principal, KMR Group Inc., United States
SPEAKER (S):
Scott R Martin, JD,MA (SPKNON), Principal
Douglas A Swain, RPh (SPKNON), Senior Functional Manager, Northeast Region, Genentech, A Member of the Roche Group, United States
 Elizabeth Desrosiers, MS,PMP (SPKNON), Director, Global Trial Management, Merck Research Laboratories, United States
Description
The session highlights how site metrics can be used to reduce risk, shorten timelines and increase productivity in clinical trials. We will explore best practices in the use of site metrics for global site selection. We will identify ways site metrics can assist in shaping strategy, defining site goals and setting timelines to meet enrollment objectives. We will also explore how quantitative analysis of performance criteria can impact the success of your sites, and your trial.